Article

jdsupra.com on 2022-08-11 18:03

Pharmaceutical Manufacturer Agrees to $900 Million Dollar False Claims Act Settlement to Resolve Kickback Claims

On July 20th, on the eve of trial, Biogen Inc. agreed to pay $900 million dollars to settle claims that the company violated the False Claims Act ...

Related news

DOJ Announces $3.8 Million Settlement to Resolve Allegations of False Claims Act and Anti-Kickback Statute Violations jdsupra.com
New Hampshire , Manchester , The Settlement
Georgia Anesthesia Operation Pays $7.2 Million to Resolve Kickback Claims jdsupra.com
Texas , Florida , Georgia , United States
Investigations Newsletter: Pharmaceutical Company Agrees to Pay $15.4 Million to Resolve Alleged False Claims Act Violations jdsupra.com
California , United States , Switzerland
Investigations Newsletter: Manufacturer to Pay Over $37.5 Million to Resolve False Claims Act Allegations jdsupra.com
California , Switzerland , United States , Massachusetts
Investigations Newsletter: Construction Company Reaches $13 Million Settlement To Resolve Kickback Allegations jdsupra.com
Canada , United Kingdom , United States , Iraq , The Settlement
HHS Proposes Revising Anti-Kickback Safe Harbor on Pharmaceutical Rebates jdsupra.com
California , United States , Switzerland , Safe Harbor
False Claims Act Fundamentals: Anti-Kickback Statute and the Stark Law jdsupra.com
Acadia Parish , Massachusetts , United States
J&J subsidiary to pay $9.75M to resolve kickback allegations seattletimes.com
Qatar , United Arab Emirates , Lebanon , Kuwait , Saudi Arabia
Sixth Circuit Affirms Dismissal of Anti-Kickback Statute-Based False Claims Act Complaint jdsupra.com
Cairns , Michigan , United States
U.S. Supreme Court Declines to Clarify Key Provisions of the False Claims and Anti-kickback Statutes jdsupra.com
Greenfield , Cairns , Lansing , Marshall Islands , United States
Investigations Newsletter: Lens Manufacturer Agrees To Pay $16.4 Million To Resolve Alleged Violations of the False Claims Act and Anti-Kickback Statute jdsupra.com
Americas , Lens
Eighth Circuit Adopts Stricter But-For Causation Standard for False Claims Act Claims based on Anti-Kickback Violations jdsupra.com
Cairns , United States
Third Circuit Reverses Dismissal Of State Law Securities Claims Against Pharmaceutical Manufacturer By Investors Who Opted Out Of Settled Federal Class Action, Holding That Securities Litigation Uniform Standards Act Did Not Preclude Opt-Out Claims jdsupra.com
California , United States , Switzerland , New Jersey
Pharma firm to pay $3.5M to resolve kickback claims bizjournals.com
Hospital to pay $3.8 million to resolve kickback claims bangordailynews.com
New Hampshire , Manchester
Investigations Newsletter: DOJ Files Complaint in AWP False Claims Act Suit Against Pharmaceutical Ingredient Seller jdsupra.com
Tallahassee , Florida , Massachusetts , Americas , Texas
Pharmaceutical Marketing and Unfair-Trade-Practices Claims jdsupra.com
Arkansas , Preemption , Texas , United States , South Carolina
Eighth Circuit Decision on Anti-Kickback Statute Offers False Claims Act Defendants Additional Tool in Their Arsenal jdsupra.com
United States
Florida Nursing Home Pays Record Settlement to Resolve Federal Anti-Kickback Case jdsupra.com
United States , The Settlement , Florida
Eighth Circuit Says “But For” Causation Required in False Claims Act Case Based on an Alleged Anti-Kickback Violation jdsupra.com
Greenfield , United States